| Adiponectin–a key adipokine in the metabolic syndrome JP Whitehead, AA Richards, IJ Hickman, GA Macdonald, JB Prins Diabetes, Obesity and Metabolism 8 (3), 264-280, 2006 | 877 | 2006 |
| Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and … IJ Hickman, JR Jonsson, JB Prins, S Ash, DM Purdie, AD Clouston, ... Gut 53 (3), 413-419, 2004 | 628 | 2004 |
| Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C IJ Hickman, AD Clouston, GA Macdonald, DM Purdie, JB Prins, S Ash, ... Gut 51 (1), 89-94, 2002 | 418 | 2002 |
| Evidence based practice guidelines for the nutritional management of malnutrition in adult patients across the continuum of care. I Hickman, L Tapsell | 344 | 2009 |
| Resveratrol does not benefit patients with nonalcoholic fatty liver disease VS Chachay, GA Macdonald, JH Martin, JP Whitehead, ... Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 2014 | 305 | 2014 |
| Impact of diabetes on the severity of liver disease IJ Hickman, GA Macdonald The American journal of medicine 120 (10), 829-834, 2007 | 271 | 2007 |
| In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy IJ Hickman, EE Powell, JB Prins, AD Clouston, S Ash, DM Purdie, ... Journal of hepatology 39 (6), 1042-1048, 2003 | 227 | 2003 |
| Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C E Vanni, ML Abate, E Gentilcore, I Hickman, R Gambino, M Cassader, ... Hepatology 50 (3), 697-706, 2009 | 187 | 2009 |
| Resveratrol–pills to replace a healthy diet? VS Chachay, CMJ Kirkpatrick, IJ Hickman, M Ferguson, JB Prins, ... British journal of clinical pharmacology 72 (1), 27-38, 2011 | 174 | 2011 |
| Adiponectin and its receptors in patients with chronic hepatitis C JR Jonsson, AR Moschen, IJ Hickman, MM Richardson, S Kaser, ... Journal of hepatology 43 (6), 929-936, 2005 | 138 | 2005 |
| Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease I Croci, NM Byrne, S Choquette, AP Hills, VS Chachay, AD Clouston, ... Gut 62 (11), 1625-1633, 2013 | 111 | 2013 |
| Changes in serum adiponectin concentrations in critical illness: a preliminary investigation B Venkatesh, I Hickman, J Nisbet, J Cohen, J Prins Critical Care 13, 1-5, 2009 | 111 | 2009 |
| Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with … AA Richards, IJ Hickman, AYH Wang, AL Jones, F Newell, BJ Mowry, ... Journal of Clinical Psychopharmacology 26 (3), 232-237, 2006 | 90 | 2006 |
| High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection AYH Wang, IJ Hickman, AA Richards, JP Whitehead, JB Prins, ... Official journal of the American College of Gastroenterology| ACG 100 (12 …, 2005 | 76 | 2005 |
| Cognitive‐behavioral treatment of nonalcoholic fatty liver disease: a propensity score‐adjusted observational study S Moscatiello, R Di Luzio, E Bugianesi, A Suppini, IJ Hickman, ... Obesity 19 (4), 763-770, 2011 | 70 | 2011 |
| Allied health research positions: a qualitative evaluation of their impact RJ Wenke, EC Ward, I Hickman, J Hulcombe, R Phillips, S Mickan Health research policy and systems 15, 1-11, 2017 | 68 | 2017 |
| Reproducibility of Fatmax and Fat Oxidation Rates during Exercise in Recreationally Trained Males I Croci, F Borrani, N Byrne, R Wood, I Hickman, X Cheneviere, ... PloS one 9 (6), e97930, 2014 | 68 | 2014 |
| Variability in adherence to an unsupervised exercise prescription in obese women RC Colley, AP Hills, TM O'Moore-Sullivan, IJ Hickman, JB Prins, ... International journal of obesity 32 (5), 837-844, 2008 | 68 | 2008 |
| Evidence of altered cortisol metabolism in critically ill patients: a prospective study B Venkatesh, J Cohen, I Hickman, J Nisbet, P Thomas, G Ward, J Hall, ... Intensive care medicine 33, 1746-1753, 2007 | 67 | 2007 |
| Treatment of clozapine‐associated obesity and diabetes with exenatide in adults with schizophrenia: a randomized controlled trial (CODEX) DJ Siskind, AW Russell, C Gamble, K Winckel, K Mayfield, S Hollingworth, ... Diabetes, Obesity and Metabolism 20 (4), 1050-1055, 2018 | 66 | 2018 |
